Filtered By:
Management: Medicaid
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 7629 results found since Jan 2013.
Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data
CONCLUSIONS: Our model has moderate power for identifying hospitalized Medicaid patients with diabetes who are at high risk of readmission. It is a template for identifying patients at risk of readmission and for adjusting comparisons of 30-day readmission rates among sites or over time.PMID:37616150 | DOI:10.37765/ajmc.2023.89409
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: Jaehyeon Yun Giovanni Filardo Vishal Ahuja Michael E Bowen Daniel F Heitjan Source Type: research
Pharmacist-led review of empagliflozin and ertugliflozin following formulary update
CONCLUSIONS: Following the HNJH Medicaid HMO's coverage update from empagliflozin to ertugliflozin, some patients received inappropriate therapy and providers accepted clinical pharmacists' recommendations to optimize therapy.PMID:37616149 | DOI:10.37765/ajmc.2023.89408
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: M Thomas Bateman Ryan Nguyen Ashwini B Navathe Caitlin McCarthy Source Type: research
Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2022
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):912-919. doi: 10.15585/mmwr.mm7234a3.ABSTRACTThree vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). CDC analyzed data from the 2022 National Immunization Survey-Teen for 16,043 adolescents aged 13-17 years to assess vaccination coverage. Birth cohort analyses were conducted to assess trends in vaccination coverage by age 13 years (i.e., before the 13th birthday) and by age 14 years (i.e., before the 14th birthday) among adolescents who were due for routine vaccination before and dur...
Source: MMWR Morb Mortal Wkl... - August 24, 2023 Category: Epidemiology Authors: Cassandra Pingali David Yankey Laurie D Elam-Evans Lauri E Markowitz Madeleine R Valier Benjamin Fredua Samuel J Crowe Carla L DeSisto Shannon Stokley James A Singleton Source Type: research
Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data
CONCLUSIONS: Our model has moderate power for identifying hospitalized Medicaid patients with diabetes who are at high risk of readmission. It is a template for identifying patients at risk of readmission and for adjusting comparisons of 30-day readmission rates among sites or over time.PMID:37616150 | DOI:10.37765/ajmc.2023.89409
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: Jaehyeon Yun Giovanni Filardo Vishal Ahuja Michael E Bowen Daniel F Heitjan Source Type: research
Pharmacist-led review of empagliflozin and ertugliflozin following formulary update
CONCLUSIONS: Following the HNJH Medicaid HMO's coverage update from empagliflozin to ertugliflozin, some patients received inappropriate therapy and providers accepted clinical pharmacists' recommendations to optimize therapy.PMID:37616149 | DOI:10.37765/ajmc.2023.89408
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: M Thomas Bateman Ryan Nguyen Ashwini B Navathe Caitlin McCarthy Source Type: research
Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data
CONCLUSIONS: Our model has moderate power for identifying hospitalized Medicaid patients with diabetes who are at high risk of readmission. It is a template for identifying patients at risk of readmission and for adjusting comparisons of 30-day readmission rates among sites or over time.PMID:37616150 | DOI:10.37765/ajmc.2023.89409
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: Jaehyeon Yun Giovanni Filardo Vishal Ahuja Michael E Bowen Daniel F Heitjan Source Type: research
Pharmacist-led review of empagliflozin and ertugliflozin following formulary update
CONCLUSIONS: Following the HNJH Medicaid HMO's coverage update from empagliflozin to ertugliflozin, some patients received inappropriate therapy and providers accepted clinical pharmacists' recommendations to optimize therapy.PMID:37616149 | DOI:10.37765/ajmc.2023.89408
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: M Thomas Bateman Ryan Nguyen Ashwini B Navathe Caitlin McCarthy Source Type: research
Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data
CONCLUSIONS: Our model has moderate power for identifying hospitalized Medicaid patients with diabetes who are at high risk of readmission. It is a template for identifying patients at risk of readmission and for adjusting comparisons of 30-day readmission rates among sites or over time.PMID:37616150 | DOI:10.37765/ajmc.2023.89409
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: Jaehyeon Yun Giovanni Filardo Vishal Ahuja Michael E Bowen Daniel F Heitjan Source Type: research
Pharmacist-led review of empagliflozin and ertugliflozin following formulary update
CONCLUSIONS: Following the HNJH Medicaid HMO's coverage update from empagliflozin to ertugliflozin, some patients received inappropriate therapy and providers accepted clinical pharmacists' recommendations to optimize therapy.PMID:37616149 | DOI:10.37765/ajmc.2023.89408
Source: The American Journal of Managed Care - August 24, 2023 Category: Health Management Authors: M Thomas Bateman Ryan Nguyen Ashwini B Navathe Caitlin McCarthy Source Type: research
Disparities in Time to Diagnosis Among Patients With Multiple Myeloma
CONCLUSION: This study suggests there may be socioeconomic disparities in TTD among patients with MM. Interventions such as patient navigation may be useful to reduce TTD among socioeconomically disadvantaged patient populations. Further studies need to be conducted to elucidate reasons for delays.PMID:37612207 | DOI:10.1016/j.clml.2023.08.003
Source: Clinical Lymphoma and Myeloma - August 23, 2023 Category: Cancer & Oncology Authors: Olivia M Lin Dana Paine Esther Gramling Manoj Menon Source Type: research
A Mixed-Methods Study to Evaluate the Feasibility and Acceptability of Implementing an Electronic Health Record Social Determinants of Health Screening Instrument into Routine Clinical Oncology Practice
CONCLUSIONS: Routine collection of SDOH in an outpatient oncology setting using an EHR instrument is feasible and does not result in increased visit time for patients or clinicians. However, staff perceptions of clinic workflow disruption were reported. Further investigation to determine whether standardized SDOH assessment can improve cancer care delivery and outcomes is ongoing.PMID:37606839 | DOI:10.1245/s10434-023-14124-9
Source: Ann Oncol - August 22, 2023 Category: Cancer & Oncology Authors: Scarlett B Hao Stephanie B Jilcott Pitts John Iasiello Christopher Mejia Ashley W Quinn Patrycja Popowicz Anastasios Mitsakos Alexander A Parikh Rebecca A Snyder Source Type: research
